Stay updated on Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial page.

Latest updates to the Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page shows a new Revision value (v3.6.6) replacing the previous v3.6.5, indicating a small platform update to the page rendering or backend components.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5 on the study record, signaling a minor metadata update. There are no visible changes to the study details or content.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page now shows the updated revision number (v3.6.4) replacing the previous v3.6.3, indicating a small release of the page rather than a change to study data.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page footer revision label was updated from v3.6.2 to v3.6.3, indicating a minor release update to the study page rendering.SummaryDifference0.1%

- Check74 days agoChange DetectedThe page revision updated from v3.6.0 to v3.6.2. This indicates a minor internal update to the page metadata.SummaryDifference0.1%

- Check88 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', indicating the study is not enrolling. New navigation/help items (How to Read a Study Record, Common Questions, How to Join a Study) and a UI revision note (Revision: v3.6.0) were added, and the Intervention header formatting was adjusted from 'Intervention / Treatment' to 'Intervention/Treatment'.SummaryDifference0.5%

Stay in the know with updates to Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial page.